Eledon Pharmaceuticals announced positive Phase 2 BESTOW trial results showing that tegoprubart, an investigational immunosuppressant, significantly improves quality of life and reduces symptom burden compared to tacrolimus in kidney transplant patients over 12 months. Patient-reported outcomes indicated sustained symptom reduction and better health-related quality of life with tegoprubart, suggesting it could become a safer, more tolerable alternative to current treatments. These findings were presented at the American Society of Nephrology Kidney Week 2026, supporting tegoprubart's potential to transform kidney transplant care.
Eledon Pharmaceuticals' Phase 2 BESTOW trial results highlight improvements in quality of life and symptom burden for kidney transplant patients. For readers following the health sector, here is Pluang's market snapshot as of Oct 26, 2026 16:51 WIB: of 150 priced health-sector US stocks, 75 rose and 29 fell today. Notable movers include GeneDx Holdings Corp (WGS) at USD 59.00 with a 1-day change of +5.08%, BioNTech SE - ADR (BNTX) at USD 84.31 with -4.32%, and Amylx Pharmaceuticals Inc (AMLX) at USD 28.35 with +4.23%.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
